TraffikGene-Tx

Gene delivery made simple

#Life_Sciences

Point Circle Elephant

TraffikGene-Tx

TraffikGene is a Spanish biotech project developing a next-generation non-viral delivery platform for nucleic acid therapies such as mRNA, siRNA, DNA, and CRISPR treatments. Its proprietary biodegradable peptide-based carriers are designed to improve targeted delivery to tissues beyond the liver while reducing the limitations of viral vectors and lipid nanoparticles. Originating from the CiQUS research center at the University of Santiago de Compostela, the project combines peptide engineering, high-throughput screening, and AI-driven analysis to advance gene therapies, RNA medicines, vaccines, and cancer treatments, supported by major European innovation funding.

The Elephants
Involved

Our Role

  • Public Funding
  • Consultancy

TraffikGene-Tx and
Inveniam

Inveniam supported the project in winning an EIC Transition Challenge.

Ready to Take Control of Your Innovation?

We look forward to learning about your innovation.